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MRIAbstract Objective: To assess the role of diffusion weighted images (DWI) MRI in differentiating
post mastoidectomy recurrent cholesteatoma from infected postoperative granulation tissue.
Materials and methods: 13 patients who performed mastoidectomy for previous cholesteatoma that
now presented with clinical and CT signs of recurrence were referred to perform non contrast MRI
using T2 and DWI sequences in order to differentiate recurrent cholesteatoma from infected
postoperative granulation tissue.
Results: 8 patients showed MRI evidence of recurrent cholesteatoma, ﬁndings were conﬁrmed
intra-operative, -ve cases showed good response on medical treatment with regression of their
clinical and radiological signs.
Conclusion: DWI MRI accurately differentiates recurrent cholesteatoma from infected post
operative granulation tissue avoiding unnecessary second look operations.
 2015 Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier B.V. All
rights reserved.1. Introduction
Cholesteatoma is an epidermal cyst of the middle ear or mas-
toid air cells and is ﬁlled by desquamated keratin. A choleste-
atoma is eradicated from the temporal bone by surgical
resection by either radical or modiﬁed radical mastoidectomy.
The choice of surgical approach depends upon the extension
into the middle ear and mastoid cavity and the status of the
ossicular chain and tympanic membrane (1). A majordisadvantage is the narrow surgical ﬁeld, a feature that is asso-
ciated with a high rate of residual and recurrent cholesteato-
mas (35% and 18%, respectively) (2).
It is difﬁcult to clinically diagnose a recurrent cholestea-
toma in a closed postoperative cavity except if a typical white
mass is seen under the drum membrane. Thus, second look
operations are the accepted management by many otologists.
These procedures can be associated with postoperative compli-
cations as infection, bleeding, delayed healing, disequilibrium,
taste disturbances, hearing loss and facial nerve paralysis. In
addition, they are done using general anesthesia with possible
anesthesia-related complications (3).
Computed tomography (CT) has been considered the
imaging technique of choice for the evaluation of middle ear
cholesteatoma in the preoperative cases, however it cannot,
differentiate between cholesteatoma, granulation tissue,
392 A.F. Abdel Ghanyretained secretions or cholesterol granuloma in the postopera-
tive bed (4).
Magnetic resonance imaging (MRI) showed good evalua-
tion capability in the evaluation of the recurrent cholesteatom.
Various MR imaging protocols have been proposed that are
mainly based on the use of delayed gadolinium-enhanced T1-
weighted sequences, diffusion weighted imaging (DWI)
sequences, or a combination of both techniques (4).
DWI images are known to have a low spatial resolution, a
high-resolution T2-weighted sequence is required to correlate
DWI ﬁndings with the patient’s anatomy. Delayed postcon-
trast T1-weighted sequence did not show signiﬁcant increase
in sensitivity or speciﬁcity in diagnosis of recurrent cholestea-
toma (4).
The echo-planar (EP) is the standard technique used in
DWI, often used for the early diagnosis of cerebral infarction.
In the temporal bone, EP DWI showed limited diagnostic
value because of susceptibility artifacts. Non-EP DW imaging
which has a slightly longer acquisition time but much less sus-
ceptibility artifacts showed a higher sensitivity and speciﬁcity
for cholesteatoma diagnosis than EP DWI (5).
The aim of this study was to assess the accuracy of noncon-
trast MRI with DWI to diagnose recurrent cholesteatoma.
2. Materials and methods
2.1. Study population
After the approval of our ethical committee and obtaining
informed consent from all patients, thirteen patients (6 male
and 7 females) with age range from 23 to 55 years with mean
age of 37 years were included in this study between August
2013 and June 2014. All patients previously resected choleste-
atoma of the middle ear, now are showing suspicious partial or
complete opacity in the operative bed on computed tomogra-
phy (CT) performed due to recurrence of discharge, pain or
progressive hearing loss. The mean interval between the mas-
toidectomy operation and the CT assessment was 30 months,
all patients were further assessed by MRI imaging of the pet-
rous temporal bone on an average of 1-3 weeks after the CT
examination, they all tolerated the study that did not exceed
about 15 min from the patient’s positioning, there were no
need for sedation or anaethesia. Positive cases were referred
for second-look surgery, while -ve cases received medical
treatment and then were followed up using the CT scanning.
2.2. CT protocol
CT examinations of the petrous bone were performed on a
128-section CT scanner (Phillips Ingenuity PET/CT Scanner,
Netherlands) with 0.32-mm section thickness. Scan conditions
were 140 kV, 300 mA s, and 1 s/rotation in helical mode. All
studies were performed without contrast and included the
entire petrous bone, reconstruction of the axial and coronal
sections was done and all images were evaluated by the same
radiologist.
2.3. MRI protocol
MRI was performed using a superconductive Philips scanner
(Intera, 1.5Tesla, Philips Healthcare, Best, The Netherlands),following the patients’ informed consent and exclusion of con-
traindications. The following sequences were acquired on the
middle ear using an 8 channel head coil and applying the
Parallel SENSE imaging is used to obtain better resolution,
faster dynamic scans and to reduce susceptibility artifacts.
1. 3D CISS (constructive interference in steady state) with a
gradient echo component
tilt angle: 70, slice thickness: 0.7 mm, repetition time (TR):
11.5 ms, echo time (TE): 5.75 ms, SENSE factor 2, ﬁeld of
view: 230 mm. Acquisition time 3 min and 50 s.
2. Axial nonecho-planar single shot turbo spin echo diffusion-
weighted imaging:
2.5 mm thick axial slices, TE: 98 ms, TR: 2000 ms, SENSE
factor 2, diffusion factor: B 1000 s/mm2, FOV: 230 mm.
Acquisition time 2 min and 50 s,
3. Coronal T2-weighted coronal spin echo (TSE).
TR/TE, 5270/119 ms; matrix, 512; section thickness,
SENSE factor 2, 3 mm; ﬁeld of view, 230 mm. Acquisition
time 3 min and 12 s.
3. Image analysis
CT and MRI images were reviewed by one radiologist not
informed about the results of surgery. cholesteatoma was diag-
nosed by the presence of suspicious opacity in the middle ear
on CT. Cholesteatoma was diagnosed on MRI in the presence
of high signal intensity on T2-weighted sequences, showing
high signal intensity and diffusion restriction on diffusion-
weighted imaging without calculation of the ADC value yet
the ADC maps were used to exclude the presence of T2 shine
through effects. No merging between the CT and MRI images
was done. Statistical analysis was done using SPSS 20.0
statistical software (SPSS Inc., Chicago, IL, USA).
4. Results
Thirteen patients (6 males and 7 females) who had been oper-
ated for previous cholesteatoma (5 were right sided and 8 were
left sided), have now presented with clinical and CT signs of
recurrence, noncontrast MRI showed recurrent cholesteatoma
(Fig. 1) in 8 patients (61.5%) 3 were right sided and 5 were left
sided while 5 patients showed no signs of recurrence (38.5%) 2
were right sided and 3 were left sided, +ve cases underwent
surgery that conﬁrmed the diagnosis in all cases with sensitiv-
ity, speciﬁcity, +ve and -ve predictive value of 100%. The
5 -ve cases were treated conservatively and followed up
clinically and by CT scans (Table 1), all showed regressive
course that conﬁrmed that the primary opacities seen were mostly
postoperative granulation tissue (Fig. 2). the average size of
cholesteatomas detected by DWI was ±4.8 mm, we did not
encounter lesions less than 3 mm, there were no false positive
or negative cases in this study group.
5. Discussion
Cholesteatomas are either primary or secondary acquired
chronic inﬂammatory lesions of the middle ear and mastoid.
The destructively and erosive epithelium requires complete sur-
gical excision. The pathogenesis of cholesteatoma as well as the
Fig. 1 (a–d) A 39 years patient underwent left sided mastoidectomy, then 2 years later he developed recurrent discharge and pain, CT
scan (a) axial and (b) coronal scans showed irregular soft tissue lesion in the operative bed with areas of bony erosions, MRI (c) T2 image
showed irregular hyperintense soft tissue lesion seen in the operative bed that shows diffusion restriction in the DWI image (d), diagnosis is
recurrent cholesteatoma, ﬁndings were conﬁrmed by surgery.
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still under research (6).
While CT is the most frequently used imaging modality for
postoperative diagnosis, a mass is found in the typical location
associated with bone destruction then a cholesteatoma is
assumed, yet ﬁndings are not speciﬁc, infected granulation tis-
sue and retained secretions show the same CT features (7).
MR imaging is superior than CT in tissue characterization.
For diagnosis of recurrent cholesteatoma, DWI has proved
their high diagnostic value. Water molecules in cholesteatomas
show diffusion restriction giving the high signal in the DWI
images (8).Table 1 Correlation between CT and MRI results with the operati
Cases Primary lesion
size by CT in mm
Recurrent cholesteatoma
diagnosed by MRI
O
co
Case 1 15 Yes Y
Case 2 10 Yes Y
Case 3 7 No N
Case 4 8 Yes Y
Case 5 7 Yes Y
Case 6 9 Yes Y
Case 7 8 Yes Y
Case 8 7 No N
Case 9 6 No N
Case 10 7 Yes Y
Case 11 6 No N
Case 12 10 Yes Y
Case 13 9 No NDW EPI has been shown to be accurate in differentiating
inﬂammatory tissue from cholesteatoma in the non-surgically
treated middle ear, as cholesteatoma demonstrates a clear
hyperintensity on DW EPI sequences in contrast to inﬂam-
matory tissue. Several reports have discussed the value of
DW EPI and late post-gadolinium T1-weighted sequences
in the detection of pre-second-look residual cholesteatoma
and postoperative recurrent cholesteatoma. No false-positive
ﬁndings have been reported in the literature, so hyperinten-
sity on DW images can be considered diagnostic for
cholesteatoma. It is clear that DW EPI has a role in the
visualization of the usually quite large recurrent or relapsingve data.
perative
nﬁrmation
Lesion size in
follow-up CT in mm
Cholesteatoma size by
DWI MRI in mm
es 8
es 6
o 2 0
es 5
es 3.5
es 4
es 4
o 3 No
o 1.5 No
es 3
o 2 No
es 5
o 2.5 No
Fig. 2 (a–f) A 45 years old patient underwent left sided mastoidectomy was referred 15 months later due to ear ache and discharge, axial
(a) and coronal (b) CT scans showed irregular erosive soft tissue lesion in the operative bed, T2 coronal MRI (c) and DWI MRI (d)
showed mild irregular mucosal thickening in the operative bed with no diffusion restriction likely representing infected granulation tissue,
after conservative management follow up axial (e) and coronal (f) CT showed regression of the inﬂammatory process excluding the
possibility of recurrent cholesteatoma.
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middle ear cholesteatoma with a size smaller than 5 mm
due to susceptibility artifacts, lower imaging matrix and rela-
tively thick slices. Recent reports have highlighted the use
and value of a non EPI-based DW sequence in the diagnosis
of primary middle ear cholesteatoma and postoperative
recurrent cholesteatoma (9).
During the past decade, fast spin-echo-based non-EPI DWI
techniques have been developed by different MR imaging
vendors. These techniques include single-shot turbo spin-echo
DWI, half-Fourier acquisition single-shot turbo spin-echo(HASTE) DWI (Siemens Medical Solutions, Erlangen,
Germany), PROPEL LER DWI, BLADE DWI (Siemens
Medical Solutions), and multi-shot DWI turbo spin echo.
These sequences minimize most susceptibility artifacts and
allow thinner sections and higher imaging matrices, yielding
sensitivities in the 90–100% range for lesions as small as
2 mm. In comparison with EPI DWI, these non-EPI DWI
techniques improve sensitivity for the detection of lesions
smaller than 5 mm and allow better lesion delineation (10).
The main diagnostic criterion for cholesteatoma at DWI is
lesion hyper-intensity, compared with the signal intensity of
MRI in diagnosis of recurrent cholesteatoma 395brain, on b= 0 s/mm2 images that persists or increases on
high b value (800–1000 s/mm2) images. Although sometimes
useful for diagnosis, ADC values have not been used as a diag-
nostic criterion. No clear-cut values have yet been established
to differentiate between cholesteatoma and other inﬂamma-
tory lesions (10). Even when non-EPI DWI techniques are used
to screen for residual disease, very small lesions (<2–3 mm) may
be missed. Leaving such small cholesteatomas is considered
safe, and some authors propose follow-up studies to detect
these lesions once they have grown larger (1). The necessity
for such follow-up studies, and the interval at which they
should be performed, are issues still to be determined.
Although not yet deﬁned, this interval should be shorter in
children, given the faster growth rate of these lesions (11).
The study results strongly correlated with recent studies on
diffusion-weighted magnetic resonance imaging showed high
sensitivity (85–90%), speciﬁcity (92–100%), positive predictive
value (92–100%) and negative predictive value (92%) in the
diagnosis of recurrent cholesteatoma after mastoidectomy sur-
gery (12). McMurphy and Oghalai (13) reported that CT alone
can be misleading in postoperative states. They considered
MRI essential for differentiation between granulation tissue,
cholesteatoma and brain herniation.
The results also correlated with those done by Emonot et al.
(14) that showed sensitivity of 79%, speciﬁcity 95% and posi-
tive predictive value 90% for diffusion weighted MRI image
for diagnosis of recurrent cholesteatoma, while Ilica et al.
(15) showed sensitivity of 94%, speciﬁcity and positive predic-
tive value of 100% of diffusion weighted MRI in diagnosis of
cholesteatoma.
The study group did not show any false negative cases, this
could attributed due to the small number of referred cases,
lesion sizes were higher than 3 mm, the -ve cases received med-
ical treatment and all improved on follow up CT scans.
Our study had some limitations, low number of cases, the
diagnosis was made by one radiologist with no interobserver
variation assessment, no comparison made was done in
between the different DWI sequences and the -ve cases were
diagnosed by decrease in CT size during follow up not by
surgery.
In conclusion DWI MRI proved to be a very valuable tool
to diagnose recurrent cholesteatoma eliminating the need
for second look surgery in cases of infected postoperative
granulation tissue.
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